Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism MKK4 inhibitors(mitogen-activated protein kinase kinase 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fatty Liver, Alcoholic | Preclinical | Germany | 01 Sep 2024 |